An interview with Shawn Singh: Chief Executive Officer and Director of VistaGen Therapeutics (Nasdaq: VTGN).

A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

An interview with Shawn Singh: Chief Executive Officer and Director of VistaGen Therapeutics (Nasdaq: VTGN). | LitMetric

An interview with Shawn Singh: Chief Executive Officer and Director of VistaGen Therapeutics (Nasdaq: VTGN).

Shawn Singh

Expert Rev Neurother

Chief Executive Officer and Director of VistaGen Therapeutics.

Published: April 2020

Download full-text PDF
Source

http://dx.doi.org/10.1080/14737175.2020.1739858 DOI Listing

Download full-text PDF	Source
http://dx.doi.org/10.1080/14737175.2020.1739858	DOI Listing

Publication Analysis

Top Keywords

interview shawn

shawn singh

singh chief

chief executive

executive officer

officer director

director vistagen

vistagen therapeutics

therapeutics nasdaq

nasdaq vtgn

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!